Physicochemical and immunological effects of adjuvant formulations with snake venom antigens for immunization of horses for antivenom production. 2023

Christopher B Fox, and Amit P Khandhar, and Lisa Khuu, and Tony Phan, and Robert Kinsey, and Daniel Cordero, and José María Gutiérrez, and Guillermo León
Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA, USA; Department of Global Health, University of Washington, Seattle, WA, USA. Electronic address: christopher.fox@aahi.org.

Enhancement of antivenom immune responses in horses through adjuvant technology improves antivenom production efficiency, but substantial local reactogenicity associated with some traditional veterinary adjuvants limits their usability. To explore modern adjuvant systems suitable for generating antivenom responses in horses, we first assessed their physicochemical compatibility with Bothrops asper snake venom. Liposome and nanoparticle aluminum adjuvants exhibited changes in particle size and phospholipid content after mixing with venom, whereas squalene emulsion-based adjuvants remained stable. Next, we evaluated serum antibody response magnitude and neutralization capacity in horses immunized with adjuvant-containing Echis ocellatus, Bitis arietans, Naja nigricollis, and Dendroaspis polylepis venom preparations. Whereas all tested adjuvants elicited significant neutralization capacity against the viperid venoms, the greatest antibody responses were generated by a squalene-in-water emulsion, thus representing a promising novel alternative for antivenom production.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D004655 Emulsions Colloids formed by the combination of two immiscible liquids such as oil and water. Lipid-in-water emulsions are usually liquid, like milk or lotion. Water-in-lipid emulsions tend to be creams. The formation of emulsions may be aided by amphiphatic molecules that surround one component of the system to form MICELLES. Emulsion
D006736 Horses Large, hoofed mammals of the family EQUIDAE. Horses are active day and night with most of the day spent seeking and consuming food. Feeding peaks occur in the early morning and late afternoon, and there are several daily periods of rest. Equus caballus,Equus przewalskii,Horse, Domestic,Domestic Horse,Domestic Horses,Horse,Horses, Domestic
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000997 Antivenins Antisera used to counteract poisoning by animal VENOMS, especially SNAKE VENOMS. Anti-Venin,Anti-Venom,Antivenin,Antivenom,Anti-Venins,Anti-Venoms,Antivenoms,Anti Venin,Anti Venins,Anti Venom,Anti Venoms
D012910 Snake Venoms Solutions or mixtures of toxic and nontoxic substances elaborated by snake (Ophidia) salivary glands (Duvernoy's gland) for the purpose of killing prey or disabling predators and delivered by grooved or hollow fangs. They usually contain enzymes, toxins, and other factors. Duvernoy's Gland Secretion,Duvernoy's Secretion,Snake Toxin,Snake Toxins,Snake Venom,Duvernoy Gland Secretion,Duvernoy Secretion,Duvernoys Gland Secretion,Duvernoys Secretion,Secretion, Duvernoy's,Secretion, Duvernoy's Gland,Toxin, Snake,Venom, Snake
D013185 Squalene A natural 30-carbon triterpene.
D017819 Viperidae A family of snakes comprising four subfamilies: Azemiopinae (the mountain viper, the sole member of this subfamily), Viperinae (true vipers), Crotalinae (pit vipers) and Causinae. They are widespread throughout the world, being found in the United States, Central and South America, Europe, Asia and Africa. Their venoms act on the blood (hemotoxic) as compared to the venom of elapids which act on the nervous system (neurotoxic). (Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, pp333-36) Asp,Bushmaster,European Viper,Azemiopinae,European Adder,Adder, European,Asps,Bushmasters,European Adders,European Vipers,Viper, European

Related Publications

Christopher B Fox, and Amit P Khandhar, and Lisa Khuu, and Tony Phan, and Robert Kinsey, and Daniel Cordero, and José María Gutiérrez, and Guillermo León
January 1997, Toxicon : official journal of the International Society on Toxinology,
Christopher B Fox, and Amit P Khandhar, and Lisa Khuu, and Tony Phan, and Robert Kinsey, and Daniel Cordero, and José María Gutiérrez, and Guillermo León
June 2015, The Cochrane database of systematic reviews,
Christopher B Fox, and Amit P Khandhar, and Lisa Khuu, and Tony Phan, and Robert Kinsey, and Daniel Cordero, and José María Gutiérrez, and Guillermo León
January 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene,
Christopher B Fox, and Amit P Khandhar, and Lisa Khuu, and Tony Phan, and Robert Kinsey, and Daniel Cordero, and José María Gutiérrez, and Guillermo León
May 1965, Nihon saikingaku zasshi. Japanese journal of bacteriology,
Christopher B Fox, and Amit P Khandhar, and Lisa Khuu, and Tony Phan, and Robert Kinsey, and Daniel Cordero, and José María Gutiérrez, and Guillermo León
July 2006, Toxicon : official journal of the International Society on Toxinology,
Christopher B Fox, and Amit P Khandhar, and Lisa Khuu, and Tony Phan, and Robert Kinsey, and Daniel Cordero, and José María Gutiérrez, and Guillermo León
April 1984, The Medical journal of Australia,
Christopher B Fox, and Amit P Khandhar, and Lisa Khuu, and Tony Phan, and Robert Kinsey, and Daniel Cordero, and José María Gutiérrez, and Guillermo León
December 2002, Journal of natural toxins,
Christopher B Fox, and Amit P Khandhar, and Lisa Khuu, and Tony Phan, and Robert Kinsey, and Daniel Cordero, and José María Gutiérrez, and Guillermo León
September 2023, Toxins,
Christopher B Fox, and Amit P Khandhar, and Lisa Khuu, and Tony Phan, and Robert Kinsey, and Daniel Cordero, and José María Gutiérrez, and Guillermo León
November 2010, The Journal of emergency medicine,
Christopher B Fox, and Amit P Khandhar, and Lisa Khuu, and Tony Phan, and Robert Kinsey, and Daniel Cordero, and José María Gutiérrez, and Guillermo León
February 2013, Basic & clinical pharmacology & toxicology,
Copied contents to your clipboard!